UBS Maintains a 'Neutral' on Molex (MOLX); More Consistent Execution
MOLX Hot Sheet
Rating Summary:1 Buy, 6 Hold, 2 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 19 | Down: 7 | New: 26
UBS maintains a 'Neutral' on Molex Incorporated (NASDAQ: MOLX) price target raised $2 to $23.
UBS analyst says, "F1Q11’s Rev/EPS of $936m/$0.47 was ahead of cons., boosted by Japan post-earthquake recovery, and pre-holiday consumer builds (see Oct 20th note). A $3.1m discrete tax expense and business tax in China partially offset the results. Orders grew q/q in Auto/Consumer, while all other end markets declined q/q. We adjust our model to reflect higher OM (est. 30bps) and sales. We foresee rev/EPS for F2Q12, FY12 of $889m/$0.41, $3.61b/$1.70 vs. prior $889m/$0.39, $3.58/$1.61."
For more ratings news on Molex Incorporated click here and for the rating history of Molex Incorporated click here.
Shares of Molex Incorporated closed at $23.30 yesterday, with a 52 week range of $18.50-$28.51.
Discover Wall Street's best ratings calls with the pros - Ratings Insider Elite. Free Trial!
UBS analyst says, "F1Q11’s Rev/EPS of $936m/$0.47 was ahead of cons., boosted by Japan post-earthquake recovery, and pre-holiday consumer builds (see Oct 20th note). A $3.1m discrete tax expense and business tax in China partially offset the results. Orders grew q/q in Auto/Consumer, while all other end markets declined q/q. We adjust our model to reflect higher OM (est. 30bps) and sales. We foresee rev/EPS for F2Q12, FY12 of $889m/$0.41, $3.61b/$1.70 vs. prior $889m/$0.39, $3.58/$1.61."
For more ratings news on Molex Incorporated click here and for the rating history of Molex Incorporated click here.
Shares of Molex Incorporated closed at $23.30 yesterday, with a 52 week range of $18.50-$28.51.
Discover Wall Street's best ratings calls with the pros - Ratings Insider Elite. Free Trial!
You May Also Be Interested In
- Needham & Company Reiterates a 'Buy' on NetApp (NTAP); Solid 4Q Overshadowed by Conservative 1Q
- UBS Cuts Price Target and Estimates on Analog Devices (ADI); Good Q2, But Slowing Growth in N-T
- Barclays Cuts PT and Estimates on Dell (DELL); Apple's (AAPL) Momentum Proves Disrupting
Create E-mail Alert Related Categories
Analyst CommentsRelated Entities
UBSSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
